BioNote, Inc. (KRX:377740)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,620.00
-50.00 (-0.88%)
At close: Feb 27, 2026
13.65%
Market Cap 569.65B
Revenue (ttm) 115.09B
Net Income (ttm) 117.65B
Shares Out 101.36M
EPS (ttm) 1,160.97
PE Ratio 4.84
Forward PE n/a
Dividend 200.00 (3.56%)
Ex-Dividend Date Mar 30, 2026
Volume 185,566
Average Volume 187,400
Open 5,670.00
Previous Close 5,670.00
Day's Range 5,540.00 - 5,710.00
52-Week Range 4,150.00 - 6,320.00
Beta 0.93
RSI 46.57
Earnings Date Feb 25, 2026

About BioNote

BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwa... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2003
Employees 298
Stock Exchange Korea Stock Exchange
Ticker Symbol 377740
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.